Genetically engineered rodent models of mammary gland carcinogenesis: an overview.
Breast cancer is a multifactorial disease that develops as a result of interactions among genetic, environmental, and hormonal factors. Multiple genetic derangements are believed to be involved in the pathogenesis of breast cancer, including the inactivation of tumor suppressor genes and/or the disregulation of proto-oncogenes. Age, hormones, and environmental factors further influence these genetic derangements. Spontaneous and chemically induced animal models of breast cancer have been limited in their usefulness. The advent of targeted gene mutations has allowed for a more specific exploration of the pathogenesis of breast cancer by creating mouse models that mimic single or multiple gene alterations found in human mammary tumors. The genes targeted in these models include mouse mammary tumor integration sites and genes that encode for growth regulators, signal transduction proteins, cell cycle proteins, and cell matrix proteinases. In this review, I summarize tumor morphology and the relevance of each model to the pathogenesis and progression of human breast cancer. These models have great potential for elucidating the multistep process of mammary gland carcinogenesis and for contributing to the identification of novel therapeutic targets.
Blackshear
P E
PE
Schering-Plough Research Institute, Lafayette, New Jersey 07848, USA. pamela.blackshear@spcorp.com
D000818:Animals; D030801:Animals, Genetically Modified; D005818:Genetic Engineering; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced* / Q000235:genetics*; D051379:Mice; D051381:Rats; D019076:Transgenes / Q000235:genetics